Archive for October, 2008
Science projects dangers to people and their well-being, including severe natural disasters, the spread of disease, loss of coastal communities, and declining crop and fish yields.
Yesterday, the Science Board Subcommittee on Food Contact Applications of BPA released its report on the Food and Drug Adminstration’s draft assessment of bisphenol A, a chemical used to strengthen all manner of plastic containers, the most damaging example being baby bottles. This story has been brewing for months, and the public health bloggers who smelled a regulatory proposal baked with industry-authored research are slamming the FDA.

Rick Weiss wrote Monday about scientific work in genetics, forensics, and satellite imaging that has helped nongovernmental organizations combat genocide and human rights abuses and bring war criminals to justice. This week also brings news from the tech sphere about an initiative to ensure the human rights to freedom of expression and privacy.
Read the rest of this post >
As the media’s interest in covering science declines, the lack of strong advocates for such coverage also comes to light.
The first stop on the road to a healthcare revolution: saliva-collection parties. But as the nascent direct-to-consumer genetic testing industry grows, what can consumers really expect to learn from these services?
There are a growing number of cases in which technologies developed for routine scientific and medical uses are finding unexpected application in the shrouded world of genocide, torture, and political oppression.

According to Iraq and Afghanistan Veterans of America, from 10 to 20 percent of Iraq war vets, or between 150,000 and 300,000 soldiers, have suffered a traumatic brain injury. Developing better ways to diagnose and treat TBI is important, but preventing it in the first place would be even better. Recent research from scientists at Lawrence Livermore National Laboratory investigates the mechanics of how blasts affect the brain and may provide an answer.
“Saving” embryos from destruction through the Human Cloning Ban Act, as conservatives suggest, would neither save them or the women carrying them to term.
There’s no shortage of good researchers with groundbreaking, unfunded ideas. So the Gates Foundation will dole out $100,000 to 104 scientists around the world with the aim of cultivating novel new preventive methods or cures for treating a variety of diseases, including HIV/AIDS and tuberculosis.
In the general absence of defined heat island policies, more environmental construction enables heat island mitigation, but often as a byproduct. A look at how urban areas bake and how green building technologies can cool them.
How will unprecedented budget deficits affect the funding of American science? The answer: No one is entirely sure, but they can’t be good.

In a surprising move last week, the Environmental Protection Agency sided with science, environmentalists, and America’s children. It has been 30 years since the United States saw a reduction in lead emissions standards, but on October 15, EPA reduced the limits from 1.5 micrograms per cubic meter to 0.15. Here’s a timeline of lead regulation in the United States over the past 100 years.

The flat-funding of the NIH since 2004 hasn’t really been flat. In fact, Weiss reminds readers that “the NIH research budget has actually now dipped to an inflation-adjusted level about 13 percent less than it was five years ago,” according to the AAAS. And to top it all off, the extreme difficultly of securing a first-time research grant is sending young scientists packing for jobs in other sectors.
Because plants and soils act as major carbon sinks, any reduction in their ability to draw down and store CO2 could have dramatic consequences for the climate. As things stand, ecosystems are already struggling to keep up with the meteoric growth in emissions over the past few decades.
As different as Singapore is from America politically and culturally, the way it is tackling its economic challenges through big investments in science and technology deserves attention from Washington insiders and the American public.

Nutritious Rice for the World runs out of the University of Washington, but pieces of the research work could be unfolding on a desktop near you. That’s because the research is one of five projects currently part of IBM’s World Community Grid. The grid allows volunteer computer users to run a small program that takes advantage of unused processing power to predict the structure of desirable rice proteins.

The Earth Policy Institute offers a rosy update on the booming wind and solar industries in every corner of the country. To get a real sense of the intense grow in these sectors, words alone don’t really do the job.

Deep brain stimulation is an experimental technique in which electrodes are implanted into the thalamus to correct the effects of neurodegenration or brain injury. Scientists have used the process to treat essential tremor since 1997 and Parkinson’s disease since 2002. The Neurophilosophy blog reports that doctors have recently used the technique to monitor brain surgery in real time—and in tempo. Neurosurgeons had their patient, the legendary bluegrass musician Eddie Adcock, play his banjo while he was undergoing deep brain stimulation.
American science succeeds because it rewards achievement, ability, and the promise of good ideas. Merit, not geography, should determine where research dollars go, because families affected by disease don’t care where the cure comes from.

It’s been about a year since MRSA, or drug-resistant staph, last made major headlines. But the news this October is about a form of Streptococcus pneumoniae, or pneumococcus, that is causing meningitis, pneumonia, and bloodstream infections, according to a report in The New York Times. Rather than resisting antibiotics, the organisms in this case may have outmaneuvered a proven vaccine.
To the pharmaceutical companies out there pushing spurious claims about their medications with millions in marketing dollars: Stop. Now. And please submit your data to the FDA for review.
Merril Goozner, a longtime Washington health and science gadfly who hosts the respected website gooznews.com, responded yesterday to my Monday posting about the negligent flat-funding of the National Institutes of Health. He makes the point that, bad as that policy has been, we should not forget that other important drivers of biomedical research and improved healthcare delivery have similarly suffered under recent Bush budgets.
Read the rest of this post >

Earlier this week, Complete Genomics announced that it will offer complete human genome sequencing for the low, low price of $5000. But as the blog Genetic Future points out, in this industry, profits will to flow to companies that can offer the best interpretation of genetic information, not just the fastest and cheapest sequencing.
It’s entirely possible for research to thrive even as the influence and relevance of science, in policy and to the average citizen, decline. Reflections on a dramatic conversation to elevate science in America.
Just over a year ago, we launched
Science Progress. Our goal was to provide a forum for progressive science policy, a venue in which those concerned about the future of the country could assess the current state of science in America.
Climate modelers work with the data they have and play a role in understanding the complexities of the Earth’s environments. But to adapt to future climate changes, we have to invest in their predictive tools.

Writing at the Switchboard blog, Nathanael Green is pleased with the conclusions of 23 scientists who co-authored the Policy Forum in Friday’s issue of Science, “Sustainable Biofuels Redux.” And just today, the Department of Energy and the U.S. Department of Agriculture announced that tomorrow they will release a new plan for accelerating the development of the sustainable biofuels industry.

Here’s a roundup of some of the science and technology policy events happening around Washington, D.C. from October 6 to October 10. Things are light this week.
Congress last week passed a continuing resolution that will keep the National Institutes of Health budget flat-out flat for the fifth year running. The policy is flat-out wrong, as Americans who have diseases that five or ten years from now should be curable are going to have to wait a lot longer.
The AAU recommendations straddle the sciences and the humanities, but the item at the top of the group’s list is the very same as the top recommendation from the National Academy of Sciences: elevate the role of the president’s science adviser to a cabinet-level position, and appoint a highly qualified person to that position quickly.
Today, the Detroit Free Press and the Detroit News both endorsed a new policy that will be on the ballot this November in Michigan, and, if passed, will allow stem cell research. Michigan has the most restrictive anti-stem cell research laws in the nation, a tragedy which is compounded by the fact that Michigan has one of the most productive biotech R&D infrastructures of any state.

Abrupt climate changes happen. To better understand these potential threats to humanity, the U.S. Department of Energy’s Office of Biological and Environmental Research recently launched the Investigation of the Magnitudes and Probabilities of Abrupt Climate Transitions program.
A U.S. district court reminds the Park Service that the agency ignored its own scientific assessment of snowmobiling’s threats to wildlife, air quality, and natural quiet in Yellowstone National Park.
Some scientists are suggesting that marine algae are responding to manmade temperature increases by generating dimethylsulfide, a gas that forms reflective clouds. The cycle is important to understand, but a geoengineering solution that exploits it will not solve our problems.

Some new products built on advances in nanotechnology improve people’s quality of life. So how come nobody’s ever heard of these wonderful new advancements? A new report released reveals that almost half of U.S. adults have heard nothing about nanotechnology. Even fewer have heard about synthetic biology.
For eight years running, the National Academy of Sciences has offered public advice on scientific appointments for the next administration and seen its advice largely ignored. This year, the tone is different, and it’s time to pay attention.